#news #biotech Epizyme’s EZH2 blocker boosts immuno-oncology response in prostate cancer models

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Epizyme’s EZH2 blocker boosts immuno-oncology response in prostate cancer models .Epizyme’s EZH2 blocker boosts immuno-oncology response in prostate cancer models
arlene.weintraub
Mon, 04/19/2021 – 09:02

from FierceBiotech: Biotech https://ift.tt/3v3dZba